Effect of Atorvastatin in Helicobacter pylori eradicatio
Phase 3
- Conditions
- Helicobacter pylori infection.
- Registration Number
- IRCT20190823044589N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
18 years or older
Indication for Helicobacter pylori eradication
Exclusion Criteria
liver disease at the same time
Diabetes at the same time
Statin use in 6 months
History of gastric surgery
History of treatment for eradication of H. pylori
Antibiotics, PPIs, histamine receptor blockers, anti-inflammatory and non-steroidal drugs, bismuth salts in the past month
Allergy to any of the antibiotics used in the study
Gastrointestinal malignancy
Active gastrointestinal bleeding
Pregnant and lactating
History of radiation therapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Helicobacter pylori eradication. Timepoint: After 4 weeks of completion of treatment. Method of measurement: 38/5000Evaluation of Helicobacter pylori fecal antigen.
- Secondary Outcome Measures
Name Time Method Drug Side effects. Timepoint: During and after the course of treatment. Method of measurement: Ask the patient.